These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12140173)

  • 1. Toxicokinetics of riddelliine, a carcinogenic pyrrolizidine alkaloid, and metabolites in rats and mice.
    Williams L; Chou MW; Yan J; Young JF; Chan PC; Doerge DR
    Toxicol Appl Pharmacol; 2002 Jul; 182(2):98-104. PubMed ID: 12140173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2003 May; (508):1-280. PubMed ID: 12844193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo.
    Yang YC; Yan J; Doerge DR; Chan PC; Fu PP; Chou MW
    Chem Res Toxicol; 2001 Jan; 14(1):101-9. PubMed ID: 11170513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine.
    Xia Q; Chou MW; Kadlubar FF; Chan PC; Fu PP
    Chem Res Toxicol; 2003 Jan; 16(1):66-73. PubMed ID: 12693032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo.
    Wang YP; Fu PP; Chou MW
    Int J Environ Res Public Health; 2005 Apr; 2(1):74-9. PubMed ID: 16705803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity.
    Xia Q; Zhao Y; Von Tungeln LS; Doerge DR; Lin G; Cai L; Fu PP
    Chem Res Toxicol; 2013 Sep; 26(9):1384-96. PubMed ID: 23937665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J; Xia Q; Chou MW; Fu PP
    Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations induced by the carcinogenic pyrrolizidine alkaloid riddelliine in the liver cII gene of transgenic big blue rats.
    Mei N; Heflich RH; Chou MW; Chen T
    Chem Res Toxicol; 2004 Jun; 17(6):814-8. PubMed ID: 15206902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full structure assignments of pyrrolizidine alkaloid DNA adducts and mechanism of tumor initiation.
    Zhao Y; Xia Q; Gamboa da Costa G; Yu H; Cai L; Fu PP
    Chem Res Toxicol; 2012 Sep; 25(9):1985-96. PubMed ID: 22857713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver.
    Chen T; Li Z; Yan J; Yang X; Salminen W
    Mutagenesis; 2012 Jan; 27(1):59-66. PubMed ID: 21976715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid.
    Chou MW; Jian Y; Williams LD; Xia Q; Churchwell M; Doerge DR; Fu PP
    Chem Res Toxicol; 2003 Sep; 16(9):1130-7. PubMed ID: 12971801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids.
    Yang M; Ma J; Ruan J; Ye Y; Fu PP; Lin G
    Arch Toxicol; 2019 Aug; 93(8):2197-2209. PubMed ID: 31222523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine.
    Chou MW; Wang YP; Yan J; Yang YC; Beger RD; Williams LD; Doerge DR; Fu PP
    Toxicol Lett; 2003 Dec; 145(3):239-47. PubMed ID: 14580895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression changes induced by the tumorigenic pyrrolizidine alkaloid riddelliine in liver of Big Blue rats.
    Mei N; Guo L; Liu R; Fuscoe JC; Chen T
    BMC Bioinformatics; 2007 Nov; 8 Suppl 7(Suppl 7):S4. PubMed ID: 18047727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gene expression profiles altered by comfrey and riddelliine in rat liver.
    Guo L; Mei N; Dial S; Fuscoe J; Chen T
    BMC Bioinformatics; 2007 Nov; 8 Suppl 7(Suppl 7):S22. PubMed ID: 18047722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential mutagenicity of riddelliine in liver endothelial and parenchymal cells of transgenic big blue rats.
    Mei N; Chou MW; Fu PP; Heflich RH; Chen T
    Cancer Lett; 2004 Nov; 215(2):151-8. PubMed ID: 15488633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a statistical dynamic model investigating the short-term cellular kinetics induced by riddelliine, a hepatic endothelial carcinogen.
    Smith MV; Nyska A; Portier C
    Toxicol Sci; 2004 Aug; 80(2):258-67. PubMed ID: 15129021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F1 mice [Cancer Lett. 193 (2003) 119-125.
    Chou MW; Yan J; Nichols J; Xia Q; Beland FA; Chan PC; Fu PP
    Cancer Lett; 2004 Apr; 207(1):119-25. PubMed ID: 15127726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.